Nortriptyline News
Landmark STAR*D Depression Study Offers ‘Sobering' Third-Round Results
New results of the nation's largest depression study show that patients who have already failed on two prior antidepressants and then switch to a different class of antidepressants have only a minimal chance at remission by...
Study: Success with third depression drug is modest
The large group of depression sufferers who haven't recovered with two common medications stand little chance of success from a third drug, says the latest report from the nation's most ambitious study of depression treatment.
CombinatoRx, Incorporated Reports Positive Results For CRx-170 In Phase 2 Proof-Of-Concept Asthma Clinical Trial
CombinatoRx, Incorporated (NASDAQ: CRXX - News) today announced positive results of its single blind, phase 2, proof-of-concept clinical trial of CRx-170 in patients with asthma. CRx-170 is a novel synergistic combination drug...
Income may influence antidepressant response
Pooled data from published studies suggest that adults from low-income neighborhoods are less likely to respond to antidepressant medication and more likely to be suicidal than those living in higher income neighborhoods.
Displaying results 6 to 9 out of 9